ResourceSpectroscopy

Using Near-Infrared Spectroscopy in Compliance with Pharma Regulations

24 Apr 2018

The pharmaceutical industry is unique with its extensive regulations. Hence, quality control is essential to ensure compliance with regulations and guidelines. In this white paper, Metrohm discusses the use of near-infrared spectroscopy (NIRS) for quality control and assurance of pharmaceutical products.

NIRS DS2500 Analyzer

Metrohm AG

With the compact NIRS DS2500, near-infrared analysis has taken yet another step into the future of routine analysis. This dedicated analyzer offers exceptional accuracy across a broad wavelength range of 400 to 2500 nm and is designed for routine analysis along the entire production chain. The predispersive Monochromator technology now being utilized in the NIRS DS2500 guarantees a high degree of versatility and stability across the entire spectral range from 400 to 2500 nm. With the maximum possible signal-noise ratio, the NIRS DS2500 simply performs, in less than one minute, analyses of both sophisticated and low-level parameters that must be very accurate. The NIRS DS2500 was created as a high-performance instrument for harsh production environments. Robust, easy-to-use and IP65 certified, it withstands humidity, dust, vibrations and temperature fluctuations.   NIRS DS2500 Analyzer Features: Compact analyzer for reflectance measurements Maximum optical performance across the entire wavelength range (400 - 2500 nm) Matching results, even in difficult environments Network-capable via LAN (local) or direct PC connection New predispersive Monochromator Optional sampling accessories

(12)

Links

Tags

Using Near-Infrared Spectroscopy in Compliance with Pharma Regulations